**Core Concept**
Polyarteritis nodosa (PAN) is a form of systemic vasculitis characterized by necrotizing inflammation of medium-sized arteries, leading to organ damage and dysfunction. This condition is often associated with an underlying infectious or autoimmune etiology.
**Why the Correct Answer is Right**
Hepatitis B virus (HBV) infection is a well-established risk factor for the development of polyarteritis nodosa. Chronic HBV infection can lead to the production of autoantibodies and the activation of immune complexes, which in turn contribute to the vasculitic process. The exact mechanism is not fully understood, but it is thought to involve the deposition of immune complexes in the walls of medium-sized arteries, triggering an inflammatory response. The presence of HBV antigens and antibodies in the serum of patients with PAN further supports this association.
**Why Each Wrong Option is Incorrect**
**Option A:** Arsenic exposure is primarily associated with a different form of vasculitis, known as Buerger's disease, which is characterized by inflammation of the small and medium-sized arteries and veins of the limbs.
**Option B:** Chlamydia pneumoniae has been implicated in various forms of vasculitis, including giant cell arteritis and Kawasaki disease, but it is not typically associated with polyarteritis nodosa.
**Option D:** Human immunodeficiency virus (HIV) infection is associated with a range of vasculitic conditions, including HIV-associated vasculitis, but it is not specifically linked to polyarteritis nodosa.
**Clinical Pearl / High-Yield Fact**
In patients with polyarteritis nodosa, the presence of HBV infection should be suspected, and appropriate testing should be performed to determine the viral status. Treatment of the underlying HBV infection, in addition to immunosuppressive therapy for the vasculitis, may be necessary to achieve optimal outcomes.
**β Correct Answer: C. Hepatitis B virus**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.